Loading…

Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers

Objective To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan. Method We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of singl...

Full description

Saved in:
Bibliographic Details
Published in:Neuropsychopharmacology reports 2024-03, Vol.44 (1), p.176-186
Main Authors: Tanibuchi, Yuko, Omiya, Soichiro, Usami, Takashi, Matsumoto, Toshihiko
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3
container_end_page 186
container_issue 1
container_start_page 176
container_title Neuropsychopharmacology reports
container_volume 44
creator Tanibuchi, Yuko
Omiya, Soichiro
Usami, Takashi
Matsumoto, Toshihiko
description Objective To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan. Method We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the “2022 Nationwide Mental Hospital Survey of Drug‐related Disorders.” Results Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD‐10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 “disorders of adult personality and behavior.” Conclusion OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed. We compared single product abusers with multiple product abusers of OTC and conducted a detailed investigation of the clinical characteristics of OTC abusers in Japan.
doi_str_mv 10.1002/npr2.12415
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b7c011e39201413d81633d80d3d7ca96</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b7c011e39201413d81633d80d3d7ca96</doaj_id><sourcerecordid>2955920733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3</originalsourceid><addsrcrecordid>eNp9ks1u1DAQgCMEolXphQdAlrgUpC3-STYJF4QifooqilCRuFn2eLLrVdZO7aRobzwCd96OJ8Fp2qrlwMHjn_n8aWxNlj1l9JhRyl-5PvBjxnNWPMj2eVHmC1aK7w_vrPeywxg3NMHTEPnjbE9UvK55Ifaz301nnQXVEViroGDAYONgIRLfEn-J4c_PX8MaUwQ_upQlR2fnzQtiwrgiSo8RQyTWkT7uYG3VECyQfvJYwOn8k-qVe00av-1VMns3eaN1qw6JcoZsx26wfdoka7rozQjDjfdJ9qhVXcTD6_kg-_b-3XnzcXF69uGkeXu6gCI9e1GZvNXYGtA6L1FzFJoWLeeFQuQGWF1RYQDyCqhWuhKKtogpD1gJRlsjDrKT2Wu82sg-2K0KO-mVlVcHPqykCulBHUpdAmUMRc0py5kwFVuKFKkRpgRVL5PrzezqR71FA-iGoLp70vsZZ9dy5S8lo7XgZVklw9G1IfiLEeMgtzYCdp1y6Mcoec0ZY9WyqBP6_B9048fg0l8lqihSkaUQiXo5UxB8jAHb22oYlVMPyamH5FUPJfjZ3fpv0ZuOSQCbgR-2w91_VPLzl698lv4F7ZXWVw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2955920733</pqid></control><display><type>article</type><title>Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley-Blackwell Titles (Open access)</source><source>PubMed Central</source><creator>Tanibuchi, Yuko ; Omiya, Soichiro ; Usami, Takashi ; Matsumoto, Toshihiko</creator><creatorcontrib>Tanibuchi, Yuko ; Omiya, Soichiro ; Usami, Takashi ; Matsumoto, Toshihiko</creatorcontrib><description>Objective To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan. Method We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the “2022 Nationwide Mental Hospital Survey of Drug‐related Disorders.” Results Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD‐10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 “disorders of adult personality and behavior.” Conclusion OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed. We compared single product abusers with multiple product abusers of OTC and conducted a detailed investigation of the clinical characteristics of OTC abusers in Japan.</description><identifier>ISSN: 2574-173X</identifier><identifier>EISSN: 2574-173X</identifier><identifier>DOI: 10.1002/npr2.12415</identifier><identifier>PMID: 38299253</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>addiction ; Adult ; Antipsychotics ; Benzodiazepines ; clinical characteristics ; Cold remedies ; Drug abuse ; Drug crimes ; drug dependence ; Drug stores ; Drug Users ; Emergency medical care ; Female ; Hospitals ; Humans ; Japan ; Medical practices ; Mental disorders ; Nonprescription drugs ; Nonprescription Drugs - adverse effects ; Online sales ; Original ; over‐the‐counter drug users ; Prescription drugs ; Psychotropic drugs ; Secondary school students ; Secondary schools ; Self-medication ; Surveys and Questionnaires ; Trends</subject><ispartof>Neuropsychopharmacology reports, 2024-03, Vol.44 (1), p.176-186</ispartof><rights>2024 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.</rights><rights>2024 The Authors. Neuropsychopharmacology Reports published by John Wiley &amp; Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3</cites><orcidid>0000-0002-1690-6793 ; 0000-0003-2286-8663</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2955920733/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2955920733?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38299253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanibuchi, Yuko</creatorcontrib><creatorcontrib>Omiya, Soichiro</creatorcontrib><creatorcontrib>Usami, Takashi</creatorcontrib><creatorcontrib>Matsumoto, Toshihiko</creatorcontrib><title>Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers</title><title>Neuropsychopharmacology reports</title><addtitle>Neuropsychopharmacol Rep</addtitle><description>Objective To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan. Method We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the “2022 Nationwide Mental Hospital Survey of Drug‐related Disorders.” Results Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD‐10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 “disorders of adult personality and behavior.” Conclusion OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed. We compared single product abusers with multiple product abusers of OTC and conducted a detailed investigation of the clinical characteristics of OTC abusers in Japan.</description><subject>addiction</subject><subject>Adult</subject><subject>Antipsychotics</subject><subject>Benzodiazepines</subject><subject>clinical characteristics</subject><subject>Cold remedies</subject><subject>Drug abuse</subject><subject>Drug crimes</subject><subject>drug dependence</subject><subject>Drug stores</subject><subject>Drug Users</subject><subject>Emergency medical care</subject><subject>Female</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Japan</subject><subject>Medical practices</subject><subject>Mental disorders</subject><subject>Nonprescription drugs</subject><subject>Nonprescription Drugs - adverse effects</subject><subject>Online sales</subject><subject>Original</subject><subject>over‐the‐counter drug users</subject><subject>Prescription drugs</subject><subject>Psychotropic drugs</subject><subject>Secondary school students</subject><subject>Secondary schools</subject><subject>Self-medication</subject><subject>Surveys and Questionnaires</subject><subject>Trends</subject><issn>2574-173X</issn><issn>2574-173X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1u1DAQgCMEolXphQdAlrgUpC3-STYJF4QifooqilCRuFn2eLLrVdZO7aRobzwCd96OJ8Fp2qrlwMHjn_n8aWxNlj1l9JhRyl-5PvBjxnNWPMj2eVHmC1aK7w_vrPeywxg3NMHTEPnjbE9UvK55Ifaz301nnQXVEViroGDAYONgIRLfEn-J4c_PX8MaUwQ_upQlR2fnzQtiwrgiSo8RQyTWkT7uYG3VECyQfvJYwOn8k-qVe00av-1VMns3eaN1qw6JcoZsx26wfdoka7rozQjDjfdJ9qhVXcTD6_kg-_b-3XnzcXF69uGkeXu6gCI9e1GZvNXYGtA6L1FzFJoWLeeFQuQGWF1RYQDyCqhWuhKKtogpD1gJRlsjDrKT2Wu82sg-2K0KO-mVlVcHPqykCulBHUpdAmUMRc0py5kwFVuKFKkRpgRVL5PrzezqR71FA-iGoLp70vsZZ9dy5S8lo7XgZVklw9G1IfiLEeMgtzYCdp1y6Mcoec0ZY9WyqBP6_B9048fg0l8lqihSkaUQiXo5UxB8jAHb22oYlVMPyamH5FUPJfjZ3fpv0ZuOSQCbgR-2w91_VPLzl698lv4F7ZXWVw</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Tanibuchi, Yuko</creator><creator>Omiya, Soichiro</creator><creator>Usami, Takashi</creator><creator>Matsumoto, Toshihiko</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1690-6793</orcidid><orcidid>https://orcid.org/0000-0003-2286-8663</orcidid></search><sort><creationdate>202403</creationdate><title>Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers</title><author>Tanibuchi, Yuko ; Omiya, Soichiro ; Usami, Takashi ; Matsumoto, Toshihiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>addiction</topic><topic>Adult</topic><topic>Antipsychotics</topic><topic>Benzodiazepines</topic><topic>clinical characteristics</topic><topic>Cold remedies</topic><topic>Drug abuse</topic><topic>Drug crimes</topic><topic>drug dependence</topic><topic>Drug stores</topic><topic>Drug Users</topic><topic>Emergency medical care</topic><topic>Female</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Japan</topic><topic>Medical practices</topic><topic>Mental disorders</topic><topic>Nonprescription drugs</topic><topic>Nonprescription Drugs - adverse effects</topic><topic>Online sales</topic><topic>Original</topic><topic>over‐the‐counter drug users</topic><topic>Prescription drugs</topic><topic>Psychotropic drugs</topic><topic>Secondary school students</topic><topic>Secondary schools</topic><topic>Self-medication</topic><topic>Surveys and Questionnaires</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanibuchi, Yuko</creatorcontrib><creatorcontrib>Omiya, Soichiro</creatorcontrib><creatorcontrib>Usami, Takashi</creatorcontrib><creatorcontrib>Matsumoto, Toshihiko</creatorcontrib><collection>Wiley-Blackwell Titles (Open access)</collection><collection>Wiley Free Archive</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Neuropsychopharmacology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanibuchi, Yuko</au><au>Omiya, Soichiro</au><au>Usami, Takashi</au><au>Matsumoto, Toshihiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers</atitle><jtitle>Neuropsychopharmacology reports</jtitle><addtitle>Neuropsychopharmacol Rep</addtitle><date>2024-03</date><risdate>2024</risdate><volume>44</volume><issue>1</issue><spage>176</spage><epage>186</epage><pages>176-186</pages><issn>2574-173X</issn><eissn>2574-173X</eissn><abstract>Objective To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan. Method We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the “2022 Nationwide Mental Hospital Survey of Drug‐related Disorders.” Results Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD‐10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 “disorders of adult personality and behavior.” Conclusion OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed. We compared single product abusers with multiple product abusers of OTC and conducted a detailed investigation of the clinical characteristics of OTC abusers in Japan.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38299253</pmid><doi>10.1002/npr2.12415</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1690-6793</orcidid><orcidid>https://orcid.org/0000-0003-2286-8663</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2574-173X
ispartof Neuropsychopharmacology reports, 2024-03, Vol.44 (1), p.176-186
issn 2574-173X
2574-173X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_b7c011e39201413d81633d80d3d7ca96
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley-Blackwell Titles (Open access); PubMed Central
subjects addiction
Adult
Antipsychotics
Benzodiazepines
clinical characteristics
Cold remedies
Drug abuse
Drug crimes
drug dependence
Drug stores
Drug Users
Emergency medical care
Female
Hospitals
Humans
Japan
Medical practices
Mental disorders
Nonprescription drugs
Nonprescription Drugs - adverse effects
Online sales
Original
over‐the‐counter drug users
Prescription drugs
Psychotropic drugs
Secondary school students
Secondary schools
Self-medication
Surveys and Questionnaires
Trends
title Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A55%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20characteristics%20of%20over%E2%80%90the%E2%80%90counter%20(OTC)%20drug%20abusers%20in%20psychiatric%20practice%20in%20Japan:%20Comparison%20of%20single%20and%20multiple%20OTC%20product%20abusers&rft.jtitle=Neuropsychopharmacology%20reports&rft.au=Tanibuchi,%20Yuko&rft.date=2024-03&rft.volume=44&rft.issue=1&rft.spage=176&rft.epage=186&rft.pages=176-186&rft.issn=2574-173X&rft.eissn=2574-173X&rft_id=info:doi/10.1002/npr2.12415&rft_dat=%3Cproquest_doaj_%3E2955920733%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2955920733&rft_id=info:pmid/38299253&rfr_iscdi=true